Prolonged of Non-Invasive Ventilation in COVID-19 Patient

Abstract

Noninvasive ventilation (NIV) is one of the alternative therapies for patients with respiratory failure or acute respiratory distress syndrome to avoid endotracheal intubation and its adverse effects. COVID-19 is a disease attacking respiratory system, inducing hypoxic-type respiratory failure. This case report describes that NIV application is somewhat useful in a number of patients with COVID-19 pneumonia suffering from respiratory failure. Nevertheless, in some cases, endotracheal intubation was done. Meticulous observation on deteriorating clinical and laboratory signs is required to make an immediate decision to switch into invasive ventilator to avoid further worsening.

Noninvasive Respiratory Devices in COVID-19

“…Some studies from China showed that early intervention with either NIV or HFNC, with or without proning, led to lower mortality and reduced need for IMV (less than 1% vs 2.3% of the national average). 6 , 12 One more study found that early proning, with either NIV or HFNC, decreased the intubation rate by 50% in moderate to severe ARDS including those having viral pneumonia. Larger studies are needed for these standardizations.…”